Human Papilloma Virus Testing Market Investment Strategy 2020 and Global Key Vendors (BD, Quest Diagnostics, Abbott, Qiagen NV, Hologic, Roche, Femasys, Seegene) | Forecast to 2025

The exclusive research report on the Global Human Papilloma Virus Testing Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global Human Papilloma Virus Testing Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

Overview of Global Human Papilloma Virus Testing Market:

The Global Human Papilloma Virus Testing Market is anticipated to attain substantial growth by the end of the forecast period (2020-2025). The Global Human Papilloma Virus Testing Market report explains that this business is predicted to register a noteworthy growth rate over the forecast period.

Significant key factors driving the growth of the Global Human Papilloma Virus Testing Market are increased procurement of the latest-generation HPV testing analyzers and test kits, coupled with the high prevalence of HPV-related infections and cancers, especially cervical and vagina. Furthermore, Human Papilloma Virus (HPV) Testing is also sometimes utilized to aid in the diagnosis of cervical intraepithelial neoplasia as well as for post-operative follow-up of cervical cancer patients and genital warts cases. The predominant devices used for HPV detection are Nucleic-acid amplification (NAAT) tests, owing to their high specificity and sensitivity as well as their ability to be adapted for high-throughput testing.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/273367 .

The Global Human Papilloma Virus Testing Market is segmented on the basis of Type, Application and Region. Based on the Type, the Global Human Papilloma Virus Testing Market is sub-segmented into Systems, Assay Kits, Services and others. On the basis of Application, the Global Human Papilloma Virus Testing Market is classified into Cervical Cancer Screening, Vaginal Cancer Screening and others.

In terms of the geographic analysis, The Human Papilloma Virus Testing Market in North America is expected to grow at the highest CAGR during the forecast period. Moreover, the presence of major players in the Human Papilloma Virus Testing Market ecosystem results in the increasing adoption of these systems in North America.

Global Human Papilloma Virus Testing Market Objectives:

1 To provide detailed information regarding key factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the Human Papilloma Virus Testing Market

2 To analyze and forecast the size of the Human Papilloma Virus Testing Market, in terms of value and volume

3 To analyze opportunities in the Human Papilloma Virus Testing Market for stakeholders and provide a competitive landscape of the market

4 To define, segment, and estimate the Human Papilloma Virus Testing Market based on deposit type and end-use industry

5 To strategically profile key players and comprehensively analyze their market shares and core competencies

6 To strategically analyze micromarkets with respect to individual growth trends, prospects, and contribution to the total market

7 To forecast the size of market segments, in terms of value, with respect to main regions, namely, Asia Pacific, North America, Europe, the Middle East & Africa, and South America

8 To track and analyze competitive developments, such as new product developments, acquisitions, expansions, partnerships, and collaborations in the Human Papilloma Virus Testing Market

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Human Papilloma Virus Testing Market Report 2020” @ https://www.businessindustryreports.com/buy-now/273367/single .

Top Leading Key Manufacturers are: Abbott Laboratories, Qiagen NV, BD, Quest Diagnostics, Hologic, Roche, Arbor Vita Corporation, Femasys, Onco Health Corporation, Seegene and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Top Medical Industry News:

Quest Diagnostics (July 08, 2020) - HPV Test Misses Twice as Many Women Who Develop Cervical Cancer as Cotesting, Quest Diagnostics Health Trends Study Finds - A Health Trends study from researchers at Quest Diagnostics and the University of Pittsburgh Medical Center (UPMC) provides new evidence that the HPV screening test is significantly less likely to detect cervical cancer and precancer than cotesting, a method which combines HPV and Pap (Papanicolaou test by liquid based cytology) testing using the same specimen.

The study is significant because it is the largest to date to assess the performance of guideline-recommended cervical cancer screening methods in a diverse population of American women in real-world care settings. It reveals stark differences in the performance of the various recommended methods in detecting cancer and precancers in women 30 years of age and older.

Published online today in the American Journal of Clinical Pathology, the peer-reviewed study assesses sensitivity rates of HPV alone, Pap alone and cotesting (HPV and Pap testing together) in detecting cancer and precancer of the cervix in nearly 19 million de-identified cotest results performed by Quest Diagnostics on behalf of 13.6 million women in the United States from 2010 to 2018. Of these cases, 1,259 were diagnosed with cervical cancer – twice the number of diagnosed cancer cases as the next largest study.

"This Health Trends analysis of a notably large and diverse population firmly validates the critical role of cotesting as a cancer and precancer screening method for women 30 and older," said R. Marshall Austin, MD, PhD, Emeritus Professor of Pathology, University of Pittsburgh Medical Center (UPMC). "It should put to rest any notion that HPV alone achieves the same bar for quality cancer screening."

HPV testing identifies the genetic material of the human papillomavirus virus, which can cause cervical cancer, while Pap identifies cellular changes on the cervix that may be or become cancer. The United States Preventive Services Task Force (USPSTF) recommends screening in women 30-65 years of age every three years with Pap, every five years with cotesting or every five years with primary HPV testing.

Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Human Papilloma Virus Testing in these regions, from 2013 to 2025 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/273367 .

Major Points in Table of Contents:

Global Human Papilloma Virus Testing Market Report 2020

1 Human papilloma virus Testing Product Definition

2 Global Human papilloma virus Testing Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Human papilloma virus Testing Shipments

2.2 Global Manufacturer Human papilloma virus Testing Business Revenue

2.3 Global Human papilloma virus Testing Market Overview

2.4 COVID-19 Impact on Human papilloma virus Testing Industry

3 Manufacturer Human papilloma virus Testing Business Introduction

3.1 Abbott Laboratories Human papilloma virus Testing Business Introduction

3.2 Qiagen NV Human papilloma virus Testing Business Introduction

3.3 Becton Human papilloma virus Testing Business Introduction

3.4 Dickinson and Company Human papilloma virus Testing Business Introduction

3.5 Quest Diagnostics Human papilloma virus Testing Business Introduction

3.6 Hologic Inc. Human papilloma virus Testing Business Introduction

………………. Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.